Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) is now available.
Shandong Weigao Group Medical Polymer Company Limited announced a potential transaction involving its subsidiary, Weigao Blood Purification, which intends to acquire 100% equity interest in WEGO Prefills Pharmaceutical Packaging Co., Ltd. This acquisition aims to create business synergies and expand the overall business scope of the Group. If completed, the transaction may be classified as a major and connected transaction under the Hong Kong Listing Rules, necessitating further disclosures.
The most recent analyst rating on (HK:1066) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a China-based company that operates in the medical industry, focusing on the research, development, production, and sales of medical products. Its primary products include medical devices for blood purification, such as hemodialyzers and dialysis machines, as well as pharmaceutical packaging materials like pre-filled drug delivery systems.
Average Trading Volume: 15,985,716
Technical Sentiment Signal: Sell
Current Market Cap: HK$25.78B
Find detailed analytics on 1066 stock on TipRanks’ Stock Analysis page.